Indian registry is among 17 worldwide recognised by the World Health Organisation as a repository for CTRI...

'If approved, the vaccine will make it easier to deploy in mass immunisation campaigns with an easy to administer formulation and delivery device'...

The results are cause for great optimism but too early for the trial as well as for the patients who wish to embark on this treatment...

Successful medical application of this technology a stunning advance in the field of tissue engineering...

Corbevax, an RBD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology...

The medicine in the past, has extensively been used for treating tapeworm infection in adults as well as children...

The first round was restricted to three centres in North 24-Parganas and the second round will take place in 69 centres...

Currently in India, there are more than 30 groups both from academia and industry, which are actively involved in developing COVID-19 vaccines...

The human safety test run in India will offer the candidate to 120 volunteers — 60 in the 18-55 years age group, and 60 in the 56-75 years age group...